Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Design TherapeuticsDSGN | Open-market sale | 25/08/13 | 25/08/14 | 562,627 sh2 trades | $5.25avg. | $2,953,791.75 | −36.0% | |
Deepa PrasadDirector | Design TherapeuticsDSGN | Open-market sale | 24/12/18 | 24/12/19 | 3,806 sh | $6.27 | $23,863.62 | −16.0% |
Arsani WilliamDirector | Design TherapeuticsDSGN | Open-market sale | 24/08/09 | 24/08/12 | 814,874 sh | $4.25 | $3,463,214.5 | −100.0% |
Design TherapeuticsDSGN | Open-market buy | 24/03/22–24/03/25 | 24/03/25 | 26,965 sh2 trades | $3.70avg. | $99,750.38 | No record | |
Heather A. BergerDirector | Design TherapeuticsDSGN | Open-market buy | 24/03/25 | 24/03/25 | 1,300 sh | $3.74 | $4,862 | No record |
Rodney W. LappeDirector | Design TherapeuticsDSGN | Open-market buy | 23/09/29 | 23/10/02 | 21,000 sh | $2.35 | $49,350 | +18.7% |
Arsani WilliamDirector | Design TherapeuticsDSGN | Open-market buyAmendment | 21/03/30 | 23/09/06 | 700,000 sh | $20.00 | $14,000,000 | No record |
Design TherapeuticsDSGN | Open-market buy | 23/08/28–23/08/29 | 23/08/30 | 2,235,000 sh2 trades | $2.40avg. | $5,373,650 | +292.2% | |
Deepa PrasadDirector | Design TherapeuticsDSGN | Open-market buy | 23/08/29 | 23/08/30 | 12,000 sh | $2.31 | $27,720 | +101.6% |